GlassScriptPhysician profile
Danielle Reynolds
NPI 1962841890
$1,128.47
in general payments reported to CMS, 2019-2025
17 companies · $96.72 in 2025
The $96.72 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $83.09 · 2021: $133 · 2022: $14.57 · 2023: $140 · 2024: $262 · 2025: $96.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $239.31 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Pfizer INC. | $140.31 | 2019-2025 | |
| Sobi, INC | $118.11 | 2019-2020 | |
| Cranial Technologies, INC | $97.85 | 2019-2023 | Doc Band |
| Corium, LLC | $75.58 | 2023-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $69.33 | 2020-2024 | Jornay Pm |
| Sanofi Pasteur INC. | $61.40 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.17 | 2019-2021 | |
| Seqirus USA INC | $54.36 | 2023-2025 | Flucelvax Quadrivalent, Flucelvax |
| Vertical Pharmaceuticals, LLC | $50.69 | 2019-2024 | Relexxii |
| Ultragenyx Pharmaceutical INC. | $44.27 | 2021-2024 | Crysvita |
| Glaxosmithkline, LLC. | $31.22 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $28.73 | 2024-2025 | Zoryve |
| Genentech USA, INC. | $18.44 | 2020 | |
| Neos Therapeutics, LP | $16.70 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $14.65 | 2019 | |
| Kaleo, INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.